SLC9A3R1 Gene Nephrolithiasisosteoporosis hypophosphatemic type 2 Genetic Test
Welcome to DNA Labs UAE, where we offer the SLC9A3R1 Gene Nephrolithiasisosteoporosis hypophosphatemic type 2 Genetic Test. This test can help diagnose individuals with Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2 and provide valuable information for treatment and management strategies.
Test Details
The SLC9A3R1 gene is associated with a condition called Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2. This condition is characterized by the formation of kidney stones (nephrolithiasis) and weak bones (osteoporosis) due to low levels of phosphate in the blood (hypophosphatemia).
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for genetic variations or mutations. In the case of Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2, NGS genetic testing can be used to identify any genetic variations or mutations in the SLC9A3R1 gene that may be causing the condition.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the SLC9A3R1 Gene Nephrolithiasis/osteoporosis, hypophosphatemic, type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SLC9A3R1 Gene Nephrolithiasis/osteoporosis, hypophosphatemic, type 2.
Conclusion
The SLC9A3R1 Gene Nephrolithiasisosteoporosis hypophosphatemic type 2 Genetic Test offered by DNA Labs UAE can help diagnose individuals with Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2 and provide valuable information for treatment and management strategies. It can also be used for genetic counseling and family planning purposes.
Test Name | SLC9A3R1 Gene Nephrolithiasisosteoporosis hypophosphatemic type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC9A3R1 Gene Nephrolithiasis/osteoporosis, hypophosphatemic, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC9A3R1 Gene Nephrolithiasis/osteoporosis, hypophosphatemic, type 2 NGS Genetic DNA Test gene SLC9A3R1 |
Test Details |
The SLC9A3R1 gene is associated with a condition called Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2. This condition is characterized by the formation of kidney stones (nephrolithiasis) and weak bones (osteoporosis) due to low levels of phosphate in the blood (hypophosphatemia). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for genetic variations or mutations. In the case of Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2, NGS genetic testing can be used to identify any genetic variations or mutations in the SLC9A3R1 gene that may be causing the condition. By identifying these genetic variations or mutations, NGS genetic testing can help in diagnosing individuals with Nephrolithiasis/Osteoporosis, Hypophosphatemic, Type 2 and provide valuable information for treatment and management strategies. It can also be used for genetic counseling and family planning purposes. |